OnKure Therapeutics, Inc. (OKUR)

Price & Market Data

Price: $4.21

Daily Change: +$0.14 / 3.33%

Daily Range: $3.58 - $4.30

Market Cap: $170,064,976

Daily Volume: 295,154

Performance Metrics

1 Week: 28.83%

1 Month: -14.46%

3 Months: 59.09%

6 Months: 64.06%

1 Year: 88.34%

YTD: 42.86%

About OnKure Therapeutics, Inc. (OKUR)

Uncover market data for OnKure Therapeutics, Inc. (OKUR). Price: 4.21, daily change: +$0.14 / 3.33%. Market cap: 170,064,976. Performance from 1-week to 6-month.

Company Details

Employees: 45

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Ka) harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company was founded in 2011 and is headquartered in Boulder, Colorado.

Selected stocks

Paranovus Entertainment Technology Ltd. (PAVS)

Gaotu Techedu Inc. (GOTU)

VolitionRX Limited (VNRX)

Skye Bioscience, Inc. (SKYE)

JIADE LIMITED (JDZG)